[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351016-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351016-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-risk-in-patients-with-pulmonary-fibrosis-and-a-rare-telomere-related-gene-variant-research-findings","Cancer risk in patients with pulmonary fibrosis and a rare telomere related gene variant - Research findings","","Rare telomere related gene (TRG) variants cause telomere biology disorders (TBD), a spectrum of age-related diseases such as pulmonary fibrosis (PF). Because most studies lacked enough older PF patients, cancer incidence in TBD-PF with pathogenic (P), likely pathogenic (LP), and variant of unknown significance (VUS) TRG variants was compared with the Netherlands general population, using observed versus expected cancer counts adjusted for age and sex.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-risk-in-patients-with-pulmonary-fibrosis-and-a-rare-telomere-related-gene-variant-research-findings/351016/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-risk-in-patients-with-pulmonary-fibrosis-and-a-rare-telomere-related-gene-variant-research-findings/351016.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about cancer risk?","Question",{"text":63,"@type":64},"It evaluates cancer incidence in patients with pulmonary fibrosis as the main manifestation of telomere biology disorders (TBD-PF) and compares it with the general population.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the expected cancer numbers calculated?",{"text":68,"@type":64},"Observed cancer counts were compared with expected counts adjusted for age and sex using data from the Netherlands Cancer Registry.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer type was found to be more frequent than expected?",{"text":72,"@type":64},"Myelodysplastic syndrome was significantly more frequently observed than expected among the TBD-PF cohort.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351016,1790196125,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","van derVis et al. Respiratory Research (2026) 27:61  \n[https://doi.org/10.1186/s12931-025-03469-2](https://doi.org/10.1186/s12931-025-03469-2)  \nRespiratory Research  \nRESEARCH Open Access  \nCancer risk in patients with pulmonary fibrosis  and a rare telomere related gene variant  \nJoanne J. van der Vis 1,2*, MartijnT. K. Maus 1, Charlotte I. de Bie3, Jasper J. van der Smagt3, Laura G. M. Daenen4, Matthijs F. M. van Oosterhout5, Jan C. Grutters 1,6 and Coline H. M. van Moorsel 1  \nAbstract  \nBackground Rare telomere related gene (TRG) variants are the cause of telomere biology disorders (TBD), a broad spectrum of age-related diseases, such as pulmonary fibrosis (PF) a disease manifesting at older age. TBD patients are at increased risk of certain types of squamous cell carcinomas and hematological malignancies. However, most studies on cancer incidence inTBDs involved relatively young cohorts in which patients with pulmonary fibrosis were underrepresented or absent. Therefore, we investigated cancer incidence in patients with pulmonary fibrosis as major manifestation ofTBD (TBD-PF) with a pathogenic (P), likely pathogenic (LP), and variant of unknown significance (VUS) TRG-variant and compared it to the general population.  \nMethods TBD-PF patients (n = 177) were retrospectively included and cancer history was collected. For each cancer type the observed number of cancers was compared with the expected number adjusted for age and sex based on data of the Netherlands Cancer Registry.  \nResults The TBD-PF cohort (median age 62.8 years, 63% male), consisted of 114 P/LP and 63 VUS carriers. Restricting the analyses to P/LP variant carriers we observed 14 patients with cancer (solid cancer n = 8 (7 . 0%); hematological cancer n = 6 (5 . 3%)) . The observed all-cancer incidence (12 . 3%) was comparable to expected (18 . 9%) in the general population, Observed/Expected incidence 0.6 (95%CI 0 .4-1. 0) . Regarding cancer types, only myelodysplastic syndrome was significantly more frequently observed than expected (Observed/Expected = 56 (95%CI 21–117)) .  \nThere were no significant differences in clinical characteristics and transplant-free survival between TBD-PF patients with and without cancer. Comparable results were obtained when patients with TRG variants classified as VUS were included.  \nConclusion All-cancer risk forTBD-PF patients was comparable to the general population. However, TBD-PF patients have an increased risk of developing myelodysplastic syndrome, underlining the importance of tailored genetic counselling and hematological surveillance.  \nKeywords Pulmonary fibrosis, Telomere biology disorder, Genetic counselling, Cancer, Myelodysplastic syndrome  \n*Correspondence:  \nJoanne J. van derVis  \n[a.vandervis@antoniusziekenhuis.nl](a.vandervis@antoniusziekenhuis.nl)  \n1ILD Center of Excellence, Member of European Reference Network-Lung, St Antonius Hospital, Nieuwegein, the Netherlands  \n2Department of Clinical Chemistry, St. Antonius Hospital, Nieuwegein, the Netherlands  \n3Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands  \n4Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands  \n5Department of Pathology, Pathologie DNA-BV, St Antonius Hospital, Nieuwegein, the Netherlands  \n6Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, the Netherlands  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s ","cbCaihWCPuM4twqU","https://ap.wps.com/l/cbCaihWCPuM4twqU","pdf",1272736,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Background\n## Telomere biology disorders and PF","[{\"question\":\"What question does the study address about cancer risk?\",\"answer\":\"It evaluates cancer incidence in patients with pulmonary fibrosis as the main manifestation of telomere biology disorders (TBD-PF) and compares it with the general population.\"},{\"question\":\"How were the expected cancer numbers calculated?\",\"answer\":\"Observed cancer counts were compared with expected counts adjusted for age and sex using data from the Netherlands Cancer Registry.\"},{\"question\":\"Which cancer type was found to be more frequent than expected?\",\"answer\":\"Myelodysplastic syndrome was significantly more frequently observed than expected among the TBD-PF cohort.\"}]","Cancer risk in patients with pulmonary fibrosis and a rare telomere related gene variant - Research findings | PDF",1790092290,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ac4f2453a8656c367bf1a4214f001d4.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/581435b41e0e2e7b2d5483dd66802413.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a90b454b6ea9e5099d6d159dd7744666.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf86e61de94a7448bf4afc89ba7b2453.webp",980,1306]